Andolast
Andolast (CR 2039) is an anti-allergic agent. Andolast can inhibit cAMP-phosphodiesterase with an IC50 value of 50 μM. Andolast can be used for the research of asthma.
For research use only. We do not sell to patients.
- CAS No.: 143330-46-5
- Formula: C15H11N9Na2O
- Molecular Weight:379.29
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
CR 2039 (10-100 mg/kg; i.v. or i.m.) inhibits the microvascular permeability changes in a model of allergic conjunctivitis in sensitized guinea-pigs[1].
CR 2039 (0-1000 μM; i.v.) inhibits dose dependently guinea-pig lung cAMP-phosphodiesterase with an IC50 value of 50 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Hartley guinea-pigs (300-500 g) [1]
-
Dosage:10-100 mg/kg
-
Administration:I.M; I.V.
-
Result:Showed dose-related significant protection against lgE-dependent bronchial anaphylaxis induced by aerosolized antigen in anesthetized guinea-pigs.
Delayed dose dependently the onset of bronchoconstriction induced by aerosolized antigen.
Chemical Information
-
CAS No. 143330-46-5
-
Molecular Weight 379.29
-
Formula C15H11N9Na2O
-
SMILES
O=C(C1=CC=C(C2=NN=NN2)C=C1)NC3=CC=C(C4=NN=NN4)C=C3.[Na].[Na]
-
Synonyms
CR 2039; Dizolast
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
DMSO : 11.36 mg/mL (29.95 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
References
[1]. Revel L, Colombo S, Ferrari F, Folco G, Rovati LC, Makovec F. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma. Eur J Pharmacol. 1992;229(1):45-53. [Content Brief]
[2]. Czuczwar SJ, Gasior M, Kozicka M, Pietrasiewicz T, Turski WA, Kleinrok Z. A potential anti-asthmatic drug, CR 2039, enhances the anticonvulsive activity of some antiepileptic drugs against pentetrazol in mice. Eur Neuropsychopharmacol. 1998;8(3):233-238. [Content Brief]
Complete Stock Solution Preparation Table
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6365 mL | 13.1825 mL | 26.3650 mL | 65.9126 mL |
| 5 mM | 0.5273 mL | 2.6365 mL | 5.2730 mL | 13.1825 mL | |
| 10 mM | 0.2637 mL | 1.3183 mL | 2.6365 mL | 6.5913 mL | |
| 15 mM | 0.1758 mL | 0.8788 mL | 1.7577 mL | 4.3942 mL | |
| 20 mM | 0.1318 mL | 0.6591 mL | 1.3183 mL | 3.2956 mL | |
| 25 mM | 0.1055 mL | 0.5273 mL | 1.0546 mL | 2.6365 mL |
Andolast Related Classifications
HY-106358A Related Classifications
Powered by Bioz